JP2021520396A5 - - Google Patents
Info
- Publication number
- JP2021520396A5 JP2021520396A5 JP2020555145A JP2020555145A JP2021520396A5 JP 2021520396 A5 JP2021520396 A5 JP 2021520396A5 JP 2020555145 A JP2020555145 A JP 2020555145A JP 2020555145 A JP2020555145 A JP 2020555145A JP 2021520396 A5 JP2021520396 A5 JP 2021520396A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- bos
- lung transplant
- diagnosed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024035414A JP2024069355A (ja) | 2018-04-11 | 2024-03-07 | 閉塞性細気管支炎症候群（ｂｏｓ）の治療に使用するためのシクロスポリン製剤 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862656226P | 2018-04-11 | 2018-04-11 | |
| US62/656,226 | 2018-04-11 | ||
| EP18172067.3 | 2018-05-14 | ||
| EP18172067 | 2018-05-14 | ||
| PCT/EP2019/058958 WO2019197406A1 (en) | 2018-04-11 | 2019-04-09 | Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (bos) |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024035414A Division JP2024069355A (ja) | 2018-04-11 | 2024-03-07 | 閉塞性細気管支炎症候群（ｂｏｓ）の治療に使用するためのシクロスポリン製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021520396A JP2021520396A (ja) | 2021-08-19 |
| JP2021520396A5 true JP2021520396A5 (https=) | 2022-04-18 |
Family
ID=66049232
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020555145A Pending JP2021520396A (ja) | 2018-04-11 | 2019-04-09 | 閉塞性細気管支炎症候群（ｂｏｓ）の治療に使用するためのシクロスポリン製剤 |
| JP2024035414A Pending JP2024069355A (ja) | 2018-04-11 | 2024-03-07 | 閉塞性細気管支炎症候群（ｂｏｓ）の治療に使用するためのシクロスポリン製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024035414A Pending JP2024069355A (ja) | 2018-04-11 | 2024-03-07 | 閉塞性細気管支炎症候群（ｂｏｓ）の治療に使用するためのシクロスポリン製剤 |
Country Status (21)
| Country | Link |
|---|---|
| US (4) | US11484566B2 (https=) |
| EP (2) | EP3773664B1 (https=) |
| JP (2) | JP2021520396A (https=) |
| CN (1) | CN112105374A (https=) |
| AU (1) | AU2019253137B2 (https=) |
| BR (1) | BR112020020564A2 (https=) |
| CA (1) | CA3094891A1 (https=) |
| CO (1) | CO2020013427A2 (https=) |
| DK (1) | DK3773664T3 (https=) |
| ES (1) | ES2980198T3 (https=) |
| FI (1) | FI3773664T3 (https=) |
| HR (1) | HRP20241022T1 (https=) |
| HU (1) | HUE067518T2 (https=) |
| IL (1) | IL277253B2 (https=) |
| LT (1) | LT3773664T (https=) |
| MX (1) | MX2020010738A (https=) |
| PL (1) | PL3773664T3 (https=) |
| RS (1) | RS65713B1 (https=) |
| SI (1) | SI3773664T1 (https=) |
| SM (1) | SMT202400220T1 (https=) |
| WO (1) | WO2019197406A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3069711A1 (en) * | 2015-03-16 | 2016-09-21 | PARI Pharma GmbH | Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection |
| EP3773664B1 (en) * | 2018-04-11 | 2024-05-01 | Breath Therapeutics GmbH | Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (bos) |
| US10736847B2 (en) * | 2018-07-03 | 2020-08-11 | Becton, Dickinson And Company | Inverting device for liposome preparation by centrifugation |
| CN114642677A (zh) * | 2020-12-21 | 2022-06-21 | 上海凯屹医药科技有限公司 | 一种稳定的含有苦丁皂苷类化合物的液体药物组合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020006901A1 (en) | 1999-02-05 | 2002-01-17 | Aldo T. Iacono | Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease |
| WO2003035030A1 (en) | 2001-10-24 | 2003-05-01 | Pari Gmbh | Kit for the preparation of a pharmaceutical composition |
| DE102006051512A1 (de) | 2005-12-06 | 2007-06-14 | Pari GmbH Spezialisten für effektive Inhalation | Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin |
| EP3069711A1 (en) | 2015-03-16 | 2016-09-21 | PARI Pharma GmbH | Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection |
| EP3773664B1 (en) * | 2018-04-11 | 2024-05-01 | Breath Therapeutics GmbH | Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (bos) |
-
2019
- 2019-04-09 EP EP19715929.6A patent/EP3773664B1/en active Active
- 2019-04-09 IL IL277253A patent/IL277253B2/en unknown
- 2019-04-09 CN CN201980025434.8A patent/CN112105374A/zh active Pending
- 2019-04-09 BR BR112020020564-8A patent/BR112020020564A2/pt unknown
- 2019-04-09 LT LTEPPCT/EP2019/058958T patent/LT3773664T/lt unknown
- 2019-04-09 PL PL19715929.6T patent/PL3773664T3/pl unknown
- 2019-04-09 EP EP24172897.1A patent/EP4400119A3/en active Pending
- 2019-04-09 SM SM20240220T patent/SMT202400220T1/it unknown
- 2019-04-09 AU AU2019253137A patent/AU2019253137B2/en active Active
- 2019-04-09 MX MX2020010738A patent/MX2020010738A/es unknown
- 2019-04-09 WO PCT/EP2019/058958 patent/WO2019197406A1/en not_active Ceased
- 2019-04-09 HR HRP20241022TT patent/HRP20241022T1/hr unknown
- 2019-04-09 SI SI201930768T patent/SI3773664T1/sl unknown
- 2019-04-09 FI FIEP19715929.6T patent/FI3773664T3/fi active
- 2019-04-09 JP JP2020555145A patent/JP2021520396A/ja active Pending
- 2019-04-09 DK DK19715929.6T patent/DK3773664T3/da active
- 2019-04-09 HU HUE19715929A patent/HUE067518T2/hu unknown
- 2019-04-09 ES ES19715929T patent/ES2980198T3/es active Active
- 2019-04-09 CA CA3094891A patent/CA3094891A1/en active Pending
- 2019-04-09 RS RS20240768A patent/RS65713B1/sr unknown
- 2019-04-09 US US17/046,307 patent/US11484566B2/en active Active
-
2020
- 2020-10-26 CO CONC2020/0013427A patent/CO2020013427A2/es unknown
-
2022
- 2022-09-26 US US17/935,140 patent/US11701403B2/en active Active
-
2023
- 2023-05-23 US US18/321,788 patent/US12178843B2/en active Active
-
2024
- 2024-03-07 JP JP2024035414A patent/JP2024069355A/ja active Pending
- 2024-11-26 US US18/959,730 patent/US20250090625A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021520396A5 (https=) | ||
| ES2309503T3 (es) | Medicamento que comprende un agonista beta 2 de larga duracion, muy potente, en combinacion con otros ingredientes activos. | |
| AU2011278096B2 (en) | Pharmaceutical compositions comprising R (+) budesonide and one or more bronchodilators | |
| JP7175506B2 (ja) | 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ | |
| JP2022544711A5 (https=) | ||
| HUE030388T2 (en) | Preparations and methods of use containing azelastine | |
| WO2015191841A1 (en) | Novel methods of treating or preventing fibrotic lung diseases | |
| Arthur et al. | Novel modes of antifungal drug administration | |
| JP7796663B2 (ja) | 過炎症性症候群の処置 | |
| IL277253B2 (en) | Formulations of cyclosporine and use in the treatment of obliterative bronchiolitis syndrome | |
| JP2019123754A (ja) | 心肺血行動態を改善するための無機亜硝酸塩 | |
| FR2638640A1 (fr) | Solution pharmaceutique | |
| JP2018058881A (ja) | 医薬組成物 | |
| MXPA06008240A (es) | Metodos de tratamiento. | |
| RU2417083C2 (ru) | Применение активаторов растворимой гуанилатциклазы для лечения острых и хронических легочных заболеваний | |
| JP2023519853A5 (https=) | ||
| JP2024520912A (ja) | １日１回（ｑｄ）の吸入による投与のためのタクロリムスの乾燥粉末製剤 | |
| US20210308180A1 (en) | Composition for preventing or treating covid-19, including gold nanoparticle as active ingredient | |
| JP2022531920A (ja) | 薬剤性肺炎の治療に使用するための血管作動性腸管ペプチド（ｖｉｐ） | |
| US20240358726A1 (en) | Specific therapeutic medical marijuana doses for stress and pain | |
| JP2003513048A (ja) | 気道狭窄の治療のための酸化窒素の使用 | |
| WO2025018279A1 (ja) | ヒト移植片対宿主病の治療薬およびその組合せ物 | |
| WO2001010423A2 (en) | Use of 5-ht3 receptor antagonists for the treatment of inflammations of the respiratory tract | |
| CN116751201A (zh) | 一种化合物或组合物及其在制备麻醉药物中的应用 | |
| JP2007504117A (ja) | 肺サーファクタントとｐｄｅ２阻害剤とを含有する組成物 |